Government's subsidy burden for FY25 is set to exceed budget estimates, rising to Rs 4.1-4.2 lakh crore, largely due to ...

Highlights Topline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025ATH434-201 trial in early-stage MSA completed in November ...

Deckers Outdoor beat both its revenue and earnings growth estimates in Q2 under Stefano Caroti’s leadership. Explore more ...

The government is expected to exceed its fiscal deficit consolidation target for FY25 due to slower-than-budgeted public ...

Shares of Cyient Ltd fell 18.58% after weak Q3 FY25 results and CEO resignation. The DET segment saw a drop in YoY profit, ...

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

FY25 revenue grew by 26.2% YoY to $267.4 million, with a 31.2% increase in marketing and sales promotion expenses.

Syngene International declined 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Indian banks face profitability challenges due to credit costs, NIM contraction, and competition, with 2025 a critical year ...

Results: The company had last reported an EBITDA margin in excess of 20% in the fourth quarter of financial year 2023.

The company's Earnings Before Interest, Taxes, Depreciation, Amortization and Restructuring (EBITDAR) stood at ₹6,059 crore.

This financial performance was driven by significant greenfield capacity additions of 3.1 GW and consistent plant performance ...